Related by context. Frequent words. (Click for all words.) 67 inflammatory autoimmune diseases 65 Panzem R 65 TELINTRA 64 Onalta 63 novel anticancer 63 PEG PAL PEGylated recombinant 63 R sorafenib tablets 63 Entereg R 62 ALN TTR 62 refractory chronic lymphocytic 62 PEG SN# 62 nonclinical studies 61 Topical Interferon Alpha 2b 61 Initiates Phase II 61 FavId 61 GVAX R 61 Excellagen 60 Soliris TM eculizumab 60 ALN TTR# 60 unique PER.C6 ® 60 Aurexis 60 DAVANAT 60 KNS # 60 Presents Positive 60 HCV protease inhibitor 59 PEG PAL 59 fibrosis IPF 59 thymalfasin 59 TELCYTA 59 TOCOSOL Paclitaxel 59 PS# [001] 59 MOZOBIL 59 ELADUR 59 squalamine 59 BCX# 59 NEBIDO R 59 active cellular immunotherapy 59 Allovectin 7 R 59 Factor VIIa 59 HGS ETR2 59 topical anti infective 59 Harbor BioSciences 59 Cloretazine R VNP#M 59 tanespimycin 58 Shigamabs ® 58 Fibrillex TM 58 Inc. Nasdaq IMGN 58 Lymphoseek ® 58 Anturol 58 addressing idiopathic pulmonary 58 forodesine 58 elotuzumab 58 Carfilzomib 58 bafetinib 58 Omigard 58 Hybridon 58 MORAb 58 SAR# [004] 58 Rebif ® 58 deforolimus 58 VQD 58 Azedra 58 UltiMAb R technology 58 Phase IIa clinical trials 58 proteasome inhibitor 57 MAP# 57 OMS# 57 Veronate 57 risks anduncertainties 57 CCX# 57 preclinical 57 CR# vcMMAE 57 cancer immunotherapies 57 Locteron ® 57 BiTE antibody 57 Sulonex 57 rNAPc2 57 RGB # 57 pradefovir 57 Phenoptin 57 preclinical toxicology 57 Exelbine 57 confirmatory Phase 3 57 non alcoholic steatohepatitis 57 NEUMUNE 57 RH1 57 RXi Pharmaceutical Corporation 57 Excellarate 57 development diagnostics combinatorial 57 ApoB SNALP 57 GRNVAC1 57 KRN# 57 ongoing Phase 1b 57 CORT # 56 MEK inhibitor 56 Metastatic Melanoma 56 orthobiologic 56 chemotherapy induced neutropenia 56 forodesine HCl 56 L DOS# 56 Myrexis